GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Cyclically Adjusted Revenue per Share

CardioGenics Holdings (CardioGenics Holdings) Cyclically Adjusted Revenue per Share : $0.00 (As of Jan. 2016)


View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

CardioGenics Holdings's adjusted revenue per share for the three months ended in Jan. 2016 was $0.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Jan. 2016.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-08), CardioGenics Holdings's current stock price is $0.0001. CardioGenics Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Jan. 2016 was $0.00. CardioGenics Holdings's Cyclically Adjusted PS Ratio of today is .


CardioGenics Holdings Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for CardioGenics Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Cyclically Adjusted Revenue per Share Chart

CardioGenics Holdings Annual Data
Trend Jul06 Jul07 Jul08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CardioGenics Holdings Quarterly Data
Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CardioGenics Holdings's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, CardioGenics Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardioGenics Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Cyclically Adjusted PS Ratio falls into.



CardioGenics Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CardioGenics Holdings's adjusted Revenue per Share data for the three months ended in Jan. 2016 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jan. 2016 (Change)*Current CPI (Jan. 2016)
=0/100.1844*100.1844
=0.000

Current CPI (Jan. 2016) = 100.1844.

CardioGenics Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200604 0.014 86.279 0.016
200607 0.005 86.595 0.006
200610 0.010 86.121 0.012
200701 0.012 86.437 0.014
200704 0.013 88.175 0.015
200707 0.008 88.491 0.009
200710 0.006 88.175 0.007
200801 0.008 88.333 0.009
200804 0.007 89.676 0.008
200807 0.009 91.493 0.010
200810 0.007 90.466 0.008
200901 0.007 89.281 0.008
200904 0.005 89.992 0.006
200907 0.000 90.624 0.000
200910 0.000 90.545 0.000
201001 0.000 90.940 0.000
201004 0.000 91.651 0.000
201007 0.000 92.283 0.000
201010 0.000 92.757 0.000
201101 0.000 93.074 0.000
201104 0.000 94.654 0.000
201107 0.000 94.812 0.000
201110 0.000 95.444 0.000
201201 0.000 95.365 0.000
201204 0.000 96.550 0.000
201207 0.000 95.997 0.000
201210 0.000 96.550 0.000
201301 0.000 95.839 0.000
201304 0.000 96.945 0.000
201307 0.000 97.261 0.000
201310 0.000 97.182 0.000
201401 0.000 97.261 0.000
201404 0.000 98.920 0.000
201407 0.000 99.315 0.000
201410 0.000 99.473 0.000
201501 0.000 98.209 0.000
201504 0.000 99.710 0.000
201507 0.000 100.579 0.000
201510 0.000 100.500 0.000
201601 0.000 100.184 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


CardioGenics Holdings  (OTCPK:CGNH) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


CardioGenics Holdings Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioGenics Holdings (CardioGenics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8
CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines